Mark Tawa
About Mark Tawa
Mark Tawa is the Vice President of Pharmaceutical Development at Alkermes, with over 20 years of experience in the pharmaceutical industry.
Company
Mark Tawa is currently with Alkermes, a global biopharmaceutical company specializing in central nervous system (CNS) diseases. Alkermes is known for its innovative drug development and manufacturing capabilities.
Title
Mark Tawa holds the position of Vice President, Pharmaceutical Development at Alkermes. In this capacity, he leads teams and oversees strategic initiatives within pharmaceutical development.
Education and Expertise
Mark Tawa holds a Master of Science degree in Chemistry from Dartmouth College, which he completed between 1999 and 2001. He also earned a Bachelor of Science degree in Chemistry from Providence College, where he studied from 1995 to 1999. His academic background has equipped him with a strong foundation in chemical and pharmaceutical sciences.
Career at Alkermes
Since joining Alkermes in 2010, Mark Tawa has progressed through multiple roles, indicating his growing responsibilities and expertise. He began as a Senior Scientist I in Pharmaceutical Chemistry, advancing to Senior Scientist II in Chemical Development, and then to Associate Director, Director, and Senior Director in Pharmaceutical Chemistry and Formulation Development before becoming Vice President, Pharmaceutical Development. His tenure at Alkermes highlights his long-term commitment and successful leadership within the company.
Experience at Transform Pharmaceuticals
Before joining Alkermes, Mark Tawa worked at Transform Pharmaceuticals as a Scientist in Pharmaceutical Sciences from 2002 to 2010. During his eight-year tenure, he made significant contributions to the field of pharmaceutical sciences, further solidifying his expertise in the industry.